{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T18:22:44Z","timestamp":1766514164356,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.yebeh.2020.107284","type":"journal-article","created":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T04:55:14Z","timestamp":1594184114000},"page":"107284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Misdiagnosis of lamotrigine toxicity as posterior circulation transient ischemic attack or stroke"],"prefix":"10.1016","volume":"111","author":[{"given":"Patsy","family":"Ramey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Osborn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard","family":"Kirshner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bassel","family":"Abou-Khalil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2020.107284_bb0005","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/00007691-199712000-00003","article-title":"Lamotrigine plasma concentrations in children and adults: influence of age and associated therapy","volume":"19","author":"Battino","year":"1997","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.yebeh.2020.107284_bb0010","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1517\/17425255.2.6.1009","article-title":"Pharmacokinetics, toxicology and safety of lamotrigine in epilepsy","volume":"2","author":"Biton","year":"2006","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.yebeh.2020.107284_bb0015","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/00002826-198908000-00009","article-title":"Long-term tolerability, pharmacokinetic and preliminary efficacy study of lamotrigine in patients with resistant partial seizures","volume":"12","author":"Mikati","year":"1989","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.yebeh.2020.107284_bb0020","doi-asserted-by":"crossref","first-page":"752","DOI":"10.5414\/CPP47752","article-title":"Population pharmacokinetics of lamotrigine in patients with epilepsy","volume":"47","author":"Milovanovic","year":"2009","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.yebeh.2020.107284_bb0025","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1212\/01.WNL.0000138424.33979.0C","article-title":"Correlating lamotrigine serum concentrations with tolerability in patients with epilepsy","volume":"63","author":"Hirsch","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2020.107284_bb0030","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.1365-2125.1998.00835.x","article-title":"Lamotrigine and therapeutic drug monitoring: retrospective survey following the introduction of a routine service","volume":"46","author":"Morris","year":"1998","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.yebeh.2020.107284_bb0035","first-page":"1","article-title":"Lamotrigine add-on for drug-resistant partial epilepsy","author":"Ramaratnam","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.yebeh.2020.107284_bb0040","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/archneurol.2010.49","article-title":"Comparative effectiveness of 10 antiepileptic drugs in older adults with epilepsy","volume":"67","author":"Arif","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/j.yebeh.2020.107284_bb0045","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1161\/01.STR.0000240329.48263.0d","article-title":"Stroke among patients with dizziness, vertigo, and imbalance in the emergency department: a population-based study","volume":"37","author":"Kerber","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.yebeh.2020.107284_bb0050","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1111\/j.1528-1167.2011.03217.x","article-title":"The effect of age and comedication on lamotrigine clearance, tolerability, and efficacy","volume":"52","author":"Arif","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2020.107284_bb0055","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.yebeh.2013.07.016","article-title":"The impact of age on lamotrigine and oxcarbazepine kinetics: a historical cohort study","volume":"29","author":"Wegner","year":"2013","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2020.107284_bb0060","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/jcph.522","article-title":"Steady-state pharmacokinetics and bioavailability of immediate-release and extended-release formulations of lamotrigine in elderly epilepsy patients: use of stable isotope methodology","volume":"55","author":"Polepally","year":"2015","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.yebeh.2020.107284_bb0065","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/0920-1211(87)90041-6","article-title":"Lamotrigine: single-dose pharmacokinetics and initial 1\u202fweek experience in refractory epilepsy","volume":"1","author":"Jawad","year":"1987","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2020.107284_bb0070","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0920-1211(91)90012-5","article-title":"Pharmacokinetics and safety of lamotrigine (Lamictal) in patients with epilepsy","volume":"10","author":"Ramsay","year":"1991","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2020.107284_bb0075","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/ane.12588","article-title":"Unexplained spikes in lamotrigine serum concentration: nonlinear elimination?","volume":"135","author":"Ramey","year":"2017","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2020.107284_bb0080","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1001\/jama.293.19.2391","article-title":"Is this patient having a stroke?","volume":"293","author":"Goldstein","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.yebeh.2020.107284_bb0085","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1212\/01.CON.0000446112.05291.35","article-title":"Cost and utility in the diagnostic evaluation of stroke","volume":"20","author":"Burke","year":"2014","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.yebeh.2020.107284_bb0090","series-title":"X-rays & imaging","article-title":"CostHelper.com\u202f>\u202fhealth & personal care\u202f>\u202ftests","author":"Cost Helper Health","year":"2019"},{"year":"2019","series-title":"Procedures","author":"New Choice Health","key":"10.1016\/j.yebeh.2020.107284_bb0095"},{"year":"2018","series-title":"Healthcare Bluebook","key":"10.1016\/j.yebeh.2020.107284_bb0100"},{"year":"2019","series-title":"MD Save","key":"10.1016\/j.yebeh.2020.107284_bb0105"},{"key":"10.1016\/j.yebeh.2020.107284_bb0110","article-title":"Over-testing for suspected pulmonary embolism in American emergency departments: the continuing epidemic","volume":"13","author":"Kline","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.yebeh.2020.107284_bb0115","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/bmc.1515","article-title":"A rapid and simple assay for lamotrigine in serum\/plasma by HPLC, and comparison with an immunoassay","volume":"25","author":"Morgan","year":"2011","journal-title":"Biomed Chromatogr"},{"key":"10.1016\/j.yebeh.2020.107284_bb0120","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/chromsci\/bmw088","article-title":"A rapid and sensitive HPLC-DAD assay to quantify lamotrigine, phenytoin and its main metabolite in samples of cultured HepaRG cells","volume":"54","author":"Ferreira","year":"2016","journal-title":"J Chromatogr Sci"},{"key":"10.1016\/j.yebeh.2020.107284_bb0125","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/bmc.1692","article-title":"Rapid and sensitive LC-MS\/MS method for quantification of lamotrigine in human plasma: application to a human pharmacokinetic study","volume":"26","author":"Hotha","year":"2012","journal-title":"Biomed Chromatogr"},{"key":"10.1016\/j.yebeh.2020.107284_bb0130","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jchromb.2017.11.040","article-title":"A simple, rapid and stability indicating validated method for quantification of lamotrigine in human plasma and dry plasma spot using LC-ESI-MS\/MS: application in clinical study","volume":"1072","author":"Namdev","year":"2018","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.yebeh.2020.107284_bb0135","first-page":"2245","article-title":"Simple, rapid and highly sensitive HPLC method for measurement of lamotrigine in human plasma and its clinical applications","volume":"29","author":"Shaikh","year":"2016","journal-title":"Pak J Pharm Sci"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505020304637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505020304637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:34:01Z","timestamp":1761503641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505020304637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":27,"alternative-id":["S1525505020304637"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2020.107284","relation":{},"ISSN":["1525-5050"],"issn-type":[{"type":"print","value":"1525-5050"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Misdiagnosis of lamotrigine toxicity as posterior circulation transient ischemic attack or stroke","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2020.107284","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107284"}}